Physician profile
Aimee E Paulson
NPI 1740463611
$4,050.37
in general payments reported to CMS, 2019-2025
33 companies · $920 in 2025
The $920 reported for 2025 was more than what 85% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $789 · 2022: $643 · 2023: $916 · 2024: $783 · 2025: $920.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,602 · Education: $17.44.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,601.50 |
| Education | $17.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $796.44 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $730.43 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $330.44 | 2021-2025 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $241.98 | 2022-2025 | |
| Amgen INC. | $192.01 | 2021-2025 | Repatha, Otezla, Repatha |
| Glaxosmithkline, LLC. | $181.04 | 2021-2025 | Trelegy Ellipta, Shingrix |
| Astellas Pharma US INC | $173.89 | 2021-2024 | Veozah |
| Pfizer INC. | $141.87 | 2023-2024 | |
| Indivior INC. | $123.00 | 2022-2025 | Sublocade |
| Lilly USA, LLC | $121.29 | 2022-2025 | Mounjaro, Zepbound, Jardiance |
| Corcept Therapeutics | $116.39 | 2025 | Korlym |
| Braeburn INC. | $87.77 | 2024 | Brixadi |
| Biohaven Pharmaceutical Holding Company LTD. | $85.44 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $75.65 | 2022-2025 | Zoryve |
| Takeda Pharmaceuticals U.S.A., INC. | $68.91 | 2022-2023 | Trintellix |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceuticals, INC. | $68.58 | 2021 | |
| Exact Sciences Corporation | $66.07 | 2025 | The Cologuard Plus Collection Kit |
| Astrazeneca Pharmaceuticals LP | $52.70 | 2023-2024 | Breztri |
| Alkermes, INC. | $42.52 | 2022-2023 | Vivitrol |
| Baxter Healthcare | $42.51 | 2025 | Hillrom - Monarch Airway Clearance System |
| Phathom Pharmaceuticals, INC. | $42.31 | 2024-2025 | Voquezna |
| Sumitomo Pharma America, INC. | $34.01 | 2023-2024 | Gemtesa |
| Sanofi-Aventis U.S. LLC | $32.54 | 2023-2024 | |
| Abbott Laboratories | $23.74 | 2025 | Freestyle Libre 3 |
| Janssen Pharmaceuticals, INC | $23.43 | 2023 | Xarelto |
| Daiichi Sankyo INC. | $21.80 | 2021 | |
| Bavarian Nordic A/S | $21.79 | 2025 | Vivotif, Vaxchora |
| Mayne Pharma Commercial LLC | $20.62 | 2025 | |
| Amarin Pharma, INC. | $19.51 | 2021 | |
| Seqirus USA INC | $18.87 | 2024 | Fluad, Flucelvax |
| Novartis Pharmaceuticals Corporation | $18.25 | 2022 | |
| Idorsia Pharmaceuticals US INC | $17.82 | 2024 | Quviviq |
| Currax Pharmaceuticals LLC | $16.75 | 2024 | Contrave |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aimee Paulson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.